Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyze the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.03437902879243661 | N/A |
Market Cap | $25.34M | N/A |
Shares Outstanding | 737.19M | N/A |
Employees | 20.00 | N/A |